Rebamipide does not protect against naproxen-induced gastric

BackgroundAims: The mucoprotective drug rebamipide is used to treat gastritis and peptic ulcers We compared the efficacy of MucostaR

The objective of the study was to evaluate efficacy of rebamipide in alleviating burning sensation of the oral mucosa in OSF in comparison with SOC

rebamipide Rebamipide hydrate ; >= 98% HPLC, powder; Rebamipide hydrate is an anti-ulcer agent

rebamipide Abstract Rebamipide is a cytoprotector developed in Japan where it has been successfully used for the treatment of stomach diseases for 30 years Initially